Metabolic pathways of carcinogenic chromium

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 5, 2002, Pages 733-738

  Gaggelli, Elena ^a   Berti, Francesco ^a   D'Amelio, Nicola ^a   Gaggelli, Nicola ^a   Valensin, Gianni ^a   Bovalini, Lucia ^a   Paffetti, Alessandro ^a   Trabalzini, Lorenza ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Asp; Chromium; Electron paramagnetic resonance; Electrospray mass spectrometry; Glu; Glutathione; LMWCr; Nuclear magnetic resonance; Ultraviolet visible spectrum

Indexed keywords

ASPARTIC ACID; CARBON 13; CARBOXYLIC ACID DERIVATIVE; CHROMIUM; GLUTAMIC ACID; GLUTATHIONE; PROTON; WATER;

ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CATTLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISPERSION; ELECTRON SPIN RESONANCE; LIVER; MASS SPECTROMETRY; METAL METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; TIME;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0036803902     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s5733     Document Type: Article

References (44)

1. Hamilton JW, Wetterhahn KE. Chromium (VI)-induced DNA damage in chick embryo liver and blood cells in vivo. Carcinogenesis 7:2085-2088 (1986).
2. Kozlowski H, Swiatek J, Bal W. Chemical bases of metal induced mutagenesis and carcinogenesis. In: Education in Advanced Chemistry. Vol 3: Environmental Chemistry and Protection (Marciniec B, Ziolkowski JJ, eds). Wroclaw:Poznan, 1996;41-60.
3. Wiegand HJ, Ottenwälder H, Bolt HM. Recent advances in biological monitoring of hexavalent chromium compounds. Sci Total Environ 71:309-315 (1988).
4. Connett PH, Wetterhahn KE. In vitro reaction of the carcinogen chromate with cellular thiols and carboxylic acids. J Am Chem Soc 107:4282-4288 (1985).
5. Kwong DWJ, Pennington DE. Stoichiometry, kinetics, and mechanisms of the chromium(VI) oxidation of L-cysteine at neutral pH. Inorg Chem 23:2528-2532 (1984).
6. Miller CA III, Cohen MD, Costa M. Complexing of acting and other nuclear proteins to DNA by cis-diamminedichloroplatinum(II) and chromium compounds. Carcinogenesis 12:269-276 (1991).
7. Voitkun V, Zhitkovich A, Costa M. Cr(II)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res 26:2024-2030 (1998).
8. Kawanishi S, Inoue S, Sano S. Mechanisms of DNA cleavage induced by sodium chromate(VI) in the presence of hydrogen peroxide. J Biol Chem 261:5952-5958 (1986).
9. Shi X, Dalal NS. On the mechanism of the chromate reduction by glutathione: ESR evidence for the glutathionyl radical and an isolable Cr(V) intermediate. Biochem Biophys Res Commun 156:137-142 (1988).
10. Shi X, Dalal NS. On the hydroxyl radical formation in the reation between hydrogen peroxide and biologically generated chromium(V) species. Arch Biochem Biophys 277:342-350 (1990).
11. Shi X, Dong Z, Dalal NS, Gannett PM. Chromate-mediated free radical generation from cysteine, penicillamine, hydrogen peroxide, and lipid hydroperoxides. Biochem Biophys Acta 1226:65-72 (1994).
12. Sugden KD, Wetterhahn KE. Direct and hydrogen peroxide-induced chromium(V) oxidation of deoxyribose in single-stranded and double-stranded calf thymus DNA. Chem Res Toxicol 10:1397-1406 (1997).
13. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Mertz W, Glinsmann W. Chromium supplementation of human subjects: effect on glucose, insulin, and lipids variables. Metabolism 32:894-899 (1983).
14. Anderson RA. Nutrition factors influencing the glucose/insulin system: chromium. J Am Coll Nutr 16:404-410 (1997).
15. Davis MC, Vincent JB. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 36:4382-4385 (1997).
16. Toepfer EW, Mertz W, Polansky M, Roginski EE, Wolf WR. Preparation of chromium-containing material of glucose tolerance factor activity from Brewer's yeast extracts and by synthesis. J Agric Food Chem 25:162-166 (1977).
17. Stearns DM, Armstrong WH. Mononuclear and binuclear chromium(III) picolinate complexes. Inorg Chem 31:5178-5184 (1992).
18. Evans GW, Bowman Td. Chromium picolinate increases membrane fluidity and rate of insulin internalization. J Inorg Biochem 46:243-250 (1992).
19. Anderson RA, Bryden NA, Polansky MM. Lack of toxicity of chromium chloride and chromium picolinate in rats. J Am Coll Nutr 6:273-279 (1997).
20. Yamamoto A, Wada O, Ono T. Isolation of biologically active low-molecular-mass chromium compound from rabbit liver. Eur J Biochem 165:627-631 (1987).
21. Yamamoto A, Wada O, Manabe S. Evidence that chromium is an essential factor for biological activity of low-molecular-weight chromium binding substance. Biochem Biophys Res Commun 163:189-193 (1989).
22. Yamamoto A, Wada O, Suzuki H. Purification and properties of biologically active chromium complex from bovine colostrum. J Nutr 118:39-45 (1988).
23. Wada O, Wu GY, Yamamoto A, Manabe S, Ono T. Purification and chromium-excretory function of low molecular-weight, chromium-binding substances from dog liver. Environ Res 32:228-239 (1983).
24. Yamamoto A, Wada O, Ono T. Distribution and chromium-binding capacity of a low-molecular-weight, chromium-binding substance in mice. J Inog Biochem 22:91-102 (1984).
25. Davis CM, Sumrall KH, Vincent JB. The biologically active form of chromium may activate a membrane phosphotyrosinephosphatase (PTP). Biochemistry 35:12963-12969 (1996).
26. Davis MC, Vincent JB. Chromium in carbohydrate and lipid metabolism. J Biol Inorg Chem 2:675-679 (1997).
27. Sumrall KH, Vincent JB. Is glucose tolerance factor an artifact produced by acid hydrolysis of low-molecular-weight chromium-binding substance? Polyhedron 16:4171-4177 (1997).
28. David MC, Royer AC, Vincent JB. Synthetic multinuclear chromium assembly activates insulin receptor kinase activity: functional odel for low-molecular-weight chromium-binding substance. Inorg Chem 35:5316-5320 (1997).
29. Davis MC, Vincent JB. Isolation and characterization of a biologically active form of chromium oligopeptide from bovine liver. Arch Biochem Biophys 339:335-343 (1997).
30. Vincent JB. Mechanisms of chromium action: low-molecular-weight chromium-binding substance. J Am Coll Nutr 18:6-12 (1999).
31. Vincent JB. The biochemistry of chromium. J Nutr 130:715-718 (2000).
32. Vincent JB. Elucidating a biological role for chromium at a molecular level. Accounts Chem Res 33:503-510 (2000).
33. Speetjens JK, Collins RA, Vincent JB, Woski SA. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chem Res Toxicol 12:483-487 (1999).
34. Ellis T, Glass M, Harton A, Folting K, Huffman JC, Vincent JB. Synthetic models for low-molecular-weight chromium-biding substance: synthesis and characterization of oxo-bridged tetranuclear chromium(III) assemblies. Inorg Chem 33:5522-5527 (1994).
35. 3 to LMWCr. J Biol Inorg Chem 5:129-136 (2000).
36. Gaggelli E, Berti F, Gaggelli N, Maccotta A, Valensin G. A homodinuclear Cr(V)-Cr(V) compelx forms from the chromate-glutathione reaction in water. J Am Chem Soc 123:8858-8859 (2001).
37. 2 (X = NCS, CI, Br, I; py = pyridine). Inorg Chem 32:1216-1221 (1993).
38. Lebedev YS. Very-high-field EPR and its applications. Appl Magn Reson 7:339-362 (1994).
39. Hypercube. Hyperchem. release 5.0 Reference manual. Waterloo, Ontario, CN:Hypercube Inc, 1997.
40. Brauer SL, Wetterhahn KE. Chromium(VI) forms a thiolate complex with glutathione. J Am Chem Soc 113:3001-3007 (1991).
41. Navon G, Valensin G. Nuclear relaxation times as a source of structural information. In: Metal Ions in Biological Systems, Vol 21 (Siegel H, ed). New York:Marcel Dekker, 1987;1-45.
42. Bertini I, Luchinat C. NMR of paramagnetic substances. Coord Chem Rev 150-29-110 (1996).
43. Solomon I. Relaxation processes in a system of two spins. Phys Rev 99:559-565 (1955).
44. Banci L, Bertini I, Luchinat C. Nuclear and Electron Relaxation. New York:VCH Publishers Inc, 1991, biologica